Bionano Genomics Reports Second Quarter 2022 Financial Results and Highlights Recent Business Progress
August 04, 2022 16:05 ET
|
Bionano Genomics
- 73% year-over-year revenue growth in Q2 2022 - Achieved all 1H 2022 ELEVATE! milestones - Strong balance sheet with $187.3 million in cash, cash equivalents, and available-for-sale securities at...
Bionano Genomics Announces Publication of Landmark Research Study in Myelodysplastic Syndrome Showing OGM Data would Result in Revised Prognostic Risk Classification or Additional Actionable Variants in 28% of Study Participants
August 01, 2022 16:05 ET
|
Bionano Genomics
SAN DIEGO, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of the first study to evaluate the utility of optical genome mapping (OGM) for...
Bionano Genomics to Report Second Quarter 2022 Financial Results and Host a Conference Call and Webcast on August 4, 2022
July 28, 2022 16:01 ET
|
Bionano Genomics
SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, August 4th, 2022 at 4:30 p.m. Eastern...
Bionano Genomics Announces its Participation at the Cancer Genomics Consortium 2022 Annual Meeting with 18 OGM Presentations Covering the Cancer Genomics Landscape
July 26, 2022 08:00 ET
|
Bionano Genomics
Dr. Alka Chaubey, chief medical officer at Bionano, will host a sponsored vendor panel presentation on the integration of optical genome mapping (OGM) and next generation sequencing (NGS) for clinical...
Bionano Genomics Announces Publication of a New Study Using OGM to Investigate Chromosome Instability during Culture of Induced Pluripotent Stem Cells
July 21, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced publication of a study using optical genome mapping (OGM) to investigate numerical and structural...
Bionano Genomics Announces Issuance of a U.S. Patent for Analysis of Small Nucleic Acid Fragments in Nanochannel Arrays
June 29, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, June 29, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that the United States Patent and Trademark Office issued US Patent No.11,359,244 on June 14,...
Bionano Genomics Announces Participation at the European Association for Cancer Research (EACR) Congress 2022 Featuring OGM Applications for Cancer Research
June 16, 2022 08:00 ET
|
Bionano Genomics
Bionano will exhibit its solutions relevant to cancer research: the Saphyr® system, NxClinical™ software and expert laboratory servicesA corporate satellite presentation by Alicia Bertolotti, Bionano,...
Bionano Genomics Announces Participation at the European Society of Human Genetics Conference (ESHG) 2022 Featuring OGM Across a Broad Range of Clinical Research Applications and a Collaborative Product Development with Hamilton
June 10, 2022 08:00 ET
|
Bionano Genomics
The Long String VANTAGE for DNA isolation, a collaborative development between Bionano and Hamilton, and the world’s first automation solution for Ultra High Molecular Weight (UHMW) extraction used in...
Hamilton and Bionano Genomics Announce World’s First Ultra High Molecular Weight DNA Extraction Automation Solution for OGM
June 09, 2022 09:00 ET
|
Bionano Genomics
SAN DIEGO, June 09, 2022 (GLOBE NEWSWIRE) -- Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the collaborative development of the Long String VANTAGE for the isolation of Ultra...
Bionano Genomics Announces Publication of a New Study Using OGM to Investigate Inversions that May Lead to Genetic Disorders
June 08, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, June 08, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the...